The Melbourne-based company confirmed the successful completion of its entitlement offer, drawing strong backing from both existing shareholders and new investors eager to support the next phase of its work.
Percheron secures fresh funding to accelerate cancer therapy ambitions
April 14, 2026 Australian Biotech
Latest Video
New Stories
-
Has any patient ever said they accept a rejection because of the Kaplan-Meier curve?
August 17, 2026 - - Latest News -
Pharmac aims to pivot toward faster process and broader value framework
August 17, 2026 - -
The 'Dispatched' Podcast - Series 5. Ep.28
August 16, 2026 - - Podcast -
Melbourne biotech pursues an oral path to changing Type 1 diabetes
August 14, 2026 - - Australian Biotech -
A plain language version of these dreadful and useless documents
August 14, 2026 - - Latest News -
An institution dominated by very clever people, but where is the wisdom?
August 14, 2026 - - Latest News -
CUREator+ backs six Australian startups with $13.5 million to advance new health technologies
August 13, 2026 - - Australian Biotech

